Join us at ESHG 2025 and learn how MGI commits in advancing clinical and population genomics
4/24/25
4/27/25
Offline
Milan, Italy
Share
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
MGI Corporate Session: Advancing Clinical and Population Genomics with MGI’s DNBSEQ and Multi-Omics Solutions
Join our must-attend session featuring real-world research in oncology and national genomics - showcasing how integrated approaches and DNBSEQ™ technology are advancing clinical genomics and personalized healthcare.
🕓 Saturday 24 May, 12:15 - 13:30 CET
📍 Room Amber 7 + 8
🍴 Lunch will be provided
REGISTER HERE
Agenda:
Building a National Genomic Infrastructure as Part of the European 1+ Million Genomes Initiative: Whole-Genome Sequencing for Population Reference and Clinical Applications. Prof. Janis Klovins, Professor & Head of the Scientific Council, Latvian Biomedical Research & Study Centre, Latvia
The Clinical Utility of Multigene Panel Analysis in Precision Oncology. Dr. Eirini Papadopoulou, International Laboratory Director, Genekor Medical S.A, Greece
Decode Half Million Genomes in Half Year: Insights from the China Kadoorie Biobank (CKB). Dr. Xin Jin, Chief Scientist & Director of the Institute of Precision Health Research at BGl-Research, China
Introducing Our Next Innovations
Live at Booth #310
Explore the DNBSEQ-T1+, DNBSEQ-G99, DNBSEQ-T7, DNBSEQ-T20x2 & Stereo-Seq spatial platforms - and speak with our experts to learn how our multi-omics solutions can advance your research.
Join us as we unveil the future of single-cell library prep - 24 May | 16:10 | Booth #310
Featured Talks and Posters at ESHG 2025
Unveiling spatial heterogeneity in medulloblastoma: a multi-omics analysis of cellular state and geographicalorganization. Dr. Li Jiankang, Session: C19-CancerComplexity: Variants,Therapies and AI-Driven Insights, Sunday, May 25
Artificial intelligence allows accurate fetal genome deduction and noninvasive prenatal diagnosis of single gene diseases and copy number variants in fetus. Dr. Ya Gao, Session: C21 - Prenatal and reproductive medicine, Sunday, May 25
Early prediction of preterm birth with cell-free RNA. Dr. Ji Yi, E-poster, at Exhibition Hall
Middle-read sequencing: bridging the gap between short-read and long-read sequencing with superior performance and cost efficiency. Dr. Heng Yi, E-poster, at Exhibition Hall
Share this article :
Share
Nov 4, 2024
Join us for the Future of Omics Conference in Stockholm
Do you want to learn about innovative solutions within Next Generation Sequencing? On November 4th we are organizing our first Future of Omics Nordic Station at Karolinska Institute in Stockholm. Experience a day with insights from leading experts in the field, engage in discussions and valuable networking.
Sep 10, 2024
MGI Tech Unveils its SEQ ALL landscape at the Future of Omics Conference
Discover insights from the "Future of Omics" event, where leading experts discussed innovations in genomics, proteomics, and metabolomics. Explore key takeaways on advancing research and technology, shaping the future of personalized medicine and healthcare. Join us in celebrating the progress in omics!
Jun 1, 2024
MGI Tech Shares New Data on Core DNEBSEQ Technology and Showcases Latest Sequencing Innovations at ESHG 2024
MGI showcased its latest innovations at the ESHG 2024, highlighting the upgraded StandardMPS 2.0 sequencing chemistry and unveiling the new DNBelab C-TaiM 4 Single-Cell Droplet Generator. European researchers presented advancements in diagnostics, population health, and more.
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).
Join our newsletter to stay up to date on features and releases.
I have read and understood MGI’s Privacy Policy, and I consent to the collection and processing of my personal data for handling, responding to my contact, receiving your newsletter as well as promotion and marketing activities.
*For Research Use Only
Not for use in diagnostic procedures (except as specifically noted).